Forbes April 18, 2024
A new artificial intelligence (AI) based strategy has significantly sped up the identification of potential new drugs to treat Parkinson’s disease. The work, published in the journal Nature Chemical Biology, could mean that new treatments for Parkinson’s reach clinical trials and patients more quickly.
Drug discovery for serious diseases is often a slow, laborious and expensive process. Developing a drug from early laboratory testing through to full approval for use in patients typically takes 10-15 years.
“This is an extremely time-consuming process – just identifying a lead candidate for further testing can take months or even years,” said Michele Vendruscolo leader of the research and professor in the Yusuf Hamied Department of Chemistry at the University of Cambridge in the...
Today's Sponsors
Today's Sponsor